Weather , , 0°C

West Syndrome Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

 Breaking News
  • No posts were found

West Syndrome Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

January 25
12:44 2021
West Syndrome Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

West Syndrome Market
West Syndrome market size in the seven major markets was estimated to be USD 171.10 Million in 2017.

(Albany, US) DelveInsight has launched a new report on ‘West Syndrome Market Insights, Epidemiology and Market Forecast– 2030 

DelveInsight’s ‘West Syndrome Market Insights, Epidemiology and Market Forecast– 2030’ report delivers an in-depth understanding of the West Syndrome, historical and forecasted epidemiology as well as the West Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of West Syndrome Facts:

  • The total diagnosed prevalent population of West Syndrome in the 7 major markets was found to be 8,057 in 2017.
  • In Japan, the diagnosed prevalence of West Syndrome was found to be 1,090 in 2017.
  • In the EU5 countries the diagnosed prevalence of West Syndrome was found to be maximum in France with 737 cases, followed by the United Kingdom with 684 cases in 2017. While, the least number of cases were found in Spain, with 445 cases in 2017.
  • The diagnosed prevalent cases of West Syndrome patients in the United States was found to be 3,999 in 2017.

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/west-syndrome-market

 

Scope of West Syndrome Report:

  • The report covers the descriptive overview of West Syndrome, explaining its causes, signs and symptoms, pathogenesis and currently available therapies.
  • Comprehensive insight has been provided into the West Syndrome epidemiology and treatment.
  • Additionally, an all-inclusive account of both the current and emerging therapies for West Syndrome are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape.
  • A detailed review of West Syndrome market; historical and forecasted is included in the report, covering the 7MM drug outreach.
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the 7MM West Syndrome market.

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/west-syndrome-market

 

West syndrome is an age-related specific epileptic encephalopathy due to multiple and diverse causes. It is characterized by a unique type of seizure called epileptic (infantile) spasms and gross EEG abnormalities of hypsarrhythmia. Usually, West syndrome consists of a characteristic triad: infantile spasms, the arrest of psychomotor development, and hypsarrhythmia, although one element may be missing.

West syndrome may be separated into two groups: the symptomatic group, which is characterized by previous existence of brain damage signs (psychomotor retardation, neurologic signs, radiologic signs, or other types of seizures) or by a known etiology, and the smaller, cryptogenic group that is characterized by a lack of previous signs of brain damage and known aetiology.

A specific cause for West Syndrome can be identified in approximately 70–75% of those affected. Any disorder that can lead to brain damage can be an underlying cause of West syndrome including trauma, brain malformations such as hemimegalencephaly or cortical dysplasia, infections, chromosomal abnormalities such as Down syndrome, neurocutaneous disorders such as tuberous sclerosis complex (TSC), Sturge Weber syndrome, incontinentia pigmenti (Bloch-Sulzberger syndrome), different metabolic/genetic diseases such as pyridoxine deficiency, nonketotic hyperglycemia, maple syrup urine disorder, phenylketonuria, mitochondrial encephalopathies and biotinidase deficiency, Otahara’s syndrome, and an abnormality (mutation) in the ARX gene or CDKL5 gene located on the X chromosome.

The spasms are linked to mental delays. The most common type of infantile spasms is the stiffening of the body. During the seizure, the child often has arms being thrown outward away from the body, the knees curled towards the body, upper body bending towards the knees. Sometimes other types of postures can also be seen but in rare cases such as legs and arms stiffened straight out from the body and head being thrown back.

The most common disorder responsible for West syndrome is tuberous sclerosis complex (TSC). TSC is an autosomal dominant genetic condition associated with seizures, eye, heart and kidney tumors and skin findings while X-linked West syndrome can be caused by a mutation in the CDKL5 gene or the ARX gene in the X chromosome. X-linked genetic disorders are conditions caused by a nonworking gene on the X chromosome and manifest mostly in males. While, females remain carrier to the condition.

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/west-syndrome-market

 

Some of West Syndrome Companies:

  • INSYS Therapeutics
  • GW Pharmaceuticals
  • BioPharm Solutions
  • And Many Others

 

West Syndrome Drugs Covered:

  • Cannabidiol (CBD) oral solution
  • Epidiolex (GWP42003-P)
  • JBPOS0101
  • And Many Others

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/west-syndrome-market

 

Table of Contents:

1 Key Insights

2 West Syndrome Market Overview at a Glance

3 Executive Summary of West Syndrome

4 West Syndrome: Disease Background and Overview

5 Diagnostic Algorithm for West Syndrome

6 Clinical Algorithm for Epileptic Spasms (Infantile Spasms) By Texas Children’s Hospital

7 Epidemiology and Patient Population

8 Country Wise-Epidemiology of West Syndrome

9 Treatment

10 Treatment Algorithm for West Syndrome

11 Guidelines for the Management and Treatment of Infantile Seizures

12 Recognized Establishments

13 Unmet Needs

14 Marketed Profiles

15 Emerging Drugs

16 West Syndrome: 7 Major Market Analysis

17 The United States Market Outlook

18 EU-5 Countries: Market Outlook

19 Japan Market Outlook

20 Case Reports

21 Market Drivers

22 Market Barriers

23 SWOT Analysis of West Syndrome

24 Appendix

25 DelveInsight Capabilities

26 Disclaimer

27 About DelveInsight

Request for Detailed TOC: https://www.delveinsight.com/sample-request/west-syndrome-market

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/west-syndrome-market

Related Articles

Calendar

March 2021
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  

Categories